Afuco™ Anti-Human SEMA3A ADCC Therapeutic Antibody, ADCC Enhanced

Anti-SEMA3A ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-Sema3A antibody enables effective prevention and treatment of a disease, in which Sema3A protein participates, such as a neurodegenerative disease, autoimmune disease, inflammatory disease, cancer, infectious disease, etc. or disseminated intravascular coagulation syndrome.
Supplier Creative Biolabs
Product # AFC-534CL
Pricing Inquiry
Host Humanized
Target SEMA3A
Species Reactivity Human
Type ADCC enhanced antibody
Storage ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C
Feedback